Ce Xie
Overview
Explore the profile of Ce Xie including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
119
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ding H, Fu R, Xie C, Wang C, Qian G
Chin J Nat Med
. 2021 Oct;
19(10):784-795.
PMID: 34688468
Sargassum fusiforme (S. fusiforme) has been used as an ingredient in Chinese herbal medicine for thousands of years. However, there are a limited number of studies concerning its therapeutic mechanism....
2.
Jiao Y, Zhao D, Gao F, Hu X, Hu X, Li M, et al.
J Physiol Biochem
. 2021 Jan;
77(1):47-61.
PMID: 33411212
Endothelial injury, which can cause endothelial inflammation and dysfunction, is an important mechanism for the development of atherosclerotic plaque. This study aims to investigate the functional role of miR-520c-3p in...
3.
Li M, Zhu H, Hu X, Gao F, Hu X, Cui Y, et al.
Can J Physiol Pharmacol
. 2020 Sep;
99(5):536-548.
PMID: 32893666
Transmembrane protein 98 () is a novel gene, and its function has not been well investigated. In a prior study, we have shown that siRNA-mediated knockdown of TMEM98 inhibited interleukin-8...
4.
Xie C, Miyasaka T
Front Mol Neurosci
. 2017 Jan;
9:158.
PMID: 28082867
Dementia includes several diseases characterized by acquired and irreversible brain dysfunctions that interfere with daily life. According to the etiology, dementia can be induced by poisoning or metabolic disorders, and...
5.
Miyasaka T, Xie C, Yoshimura S, Shinzaki Y, Yoshina S, Kage-Nakadai E, et al.
Neurobiol Aging
. 2016 Mar;
39:69-81.
PMID: 26923403
Tau is a key protein in the pathogenesis of various neurodegenerative diseases, which are categorized as tauopathies. Because the extent of tau pathologies is closely linked to that of neuronal...
6.
Xie C, Soeda Y, Shinzaki Y, In Y, Tomoo K, Ihara Y, et al.
J Neurochem
. 2015 Jul;
135(1):19-26.
PMID: 26134402
The carboxyl-terminal sequence of tau composes the framework for its intracellular inclusions that appear in diverse neurodegenerative disorders known as tauopathies. However, microtubule-associated protein 2 (MAP2), which contains a homologous...
7.
Xie C, Miyasaka T, Yoshimura S, Hatsuta H, Yoshina S, Kage-Nakadai E, et al.
PLoS One
. 2014 Mar;
9(2):e89796.
PMID: 24587039
Microtubule-associated protein 2 (MAP2) and Tau are abundant neuronal microtubule-associated proteins. Both proteins have highly homologous carboxyl-terminal sequences that function as microtubule-binding domains. Whereas Tau is widely accepted as a...
8.
Katayama T, Watanabe M, Tanaka H, Hino M, Miyakawa T, Ohki T, et al.
Am J Physiol Heart Circ Physiol
. 2009 Nov;
298(2):H505-14.
PMID: 19933418
We have been searching for a mechanism to induce smooth muscle contraction that is not associated with phosphorylation of the regulatory light chain (RLC) of smooth muscle myosin (Nakamura A,...
9.
Xie C, Zhang Y, Wang H, Matsumoto A, Nakamura A, Ishikawa R, et al.
IUBMB Life
. 2009 Oct;
61(11):1092-8.
PMID: 19859981
Myosin light-chain kinase (MLCK) comprised of N-terminal actin-binding domain, central catalytic domain, and C-terminal myosin-binding domain. It exerted not only kinase activity to phosphorylate 20 kDa regulatory light chain of...
10.
Wang H, Nakamura A, Matsumoto A, Yoshiyama S, Qin X, Ye L, et al.
Am J Physiol Heart Circ Physiol
. 2009 Feb;
296(5):H1683-93.
PMID: 19234090
The actin-myosin interaction of vascular smooth muscle cells (VSMCs) is regulated by myosin light chain kinase (MLCK), which is a fusion protein of the central catalytic domain with the N-terminal...